A8356

APR 101

≥98% (HPLC), solid

• Sinónimos: (2R)-2-[([1,1′-Biphenyl]-4-ylsulfonyl)(1-methylethoxy)amino]-N-hydroxy-3-methyl-butanamide, (R)-N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamide
• Fórmula empírica (notación de Hill): C₂₀H₂₆N₂O₅S
• Número CAS: 849773-64-4
• Peso molecular: 406.50
• NACRES: NA.77
• PubChem Substance ID: 329770956
• UNSPSC Code: 12352200
• MDL number: MFCD09753277
• Assay: ≥98% (HPLC)
• Form: solid

Propiedades

• assay: ≥98% (HPLC)
• form: solid
• solubility: DMSO: >20 mg/mL, H₂O: insoluble
• storage temp.: −20°C
• SMILES string: CC(C)ON([C@H](C(C)C)C(=O)NO)S(=O)(=O)c1ccc(cc1)-c2ccccc2
• InChI: 1S/C20H26N2O5S/c1-14(2)19(20(23)21-24)22(27-15(3)4)28(25,26)18-12-10-17(11-13-18)16-8-6-5-7-9-16/h5-15,19,24H,1-4H3,(H,21,23)/t19-/m1/s1
• InChI key: DGZZVIWCMGVHGV-LJQANCHMSA-N

Descripción

Application

ARP 101 is a MMP-2 selective inhibitor. ARP 101 has diverse physiological roles including wound healing, cancer metastasis, angiogenesis, tissue remodeling in development, and embryogenesis.

Biochem/physiol Actions

ARP 101 is a MMP-2 selective inhibitor (Gelatinase A, EC 3.4.24.24; TBE-1; LG4A; MONA; Type IV Collagenase). ARP 101 has diverse physiological roles including wound healing, cancer metastasis, angiogenesis, tissue remodeling in development and embryogenesis. IC₅₀ = 0.81 nM on MMP-2.

ARP 101 is a MMP-2 selective inhibitor.

Información de seguridad

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• pcodes: P264 - P270 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral
• Clase de almacenamiento: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges